Immune System News and Research

RSS

Government provides new guidance for living with COVID

People at risk of serious illness from COVID-19, and eligible for treatments, will continue to get free tests to use if they develop symptoms, along with NHS and adult social care staff and those in other high-risk settings, Health and Social Care Secretary Sajid Javid announced today (Tuesday 29 March).

29 Mar 2022

Study finds less diverse circulating antibodies in aging killifish

As we age, our immune system works less well. We become more susceptible to infections and vaccinations no longer work as effectively.

29 Mar 2022

The different actions of CBD in SARS-CoV-2 infection

An article has described the role of cannabidiol as a potential inhibitor of hyperinflammation in SARS-CoV-2 infection.

29 Mar 2022

One year after severe COVID-19, T cells persist against SARS-CoV-2

In a recently published article in the journal eBioMedicine, scientists have demonstrated that critically ill coronavirus disease 2019 (COVID-19) patients are capable of generating durable memory T cell response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for more than one year after hospital discharge.

28 Mar 2022

Tumor cells camouflage as platelets to go undetected in the bloodstream, finds study

The Liquid Biopsy and Cancer Interception research group—part of the Biohealth Research Institute in Granada (ibs.GRANADA), in which researchers from the University of Granada (UGR) participate—has discovered that tumor cells pass themselves off as platelets to go undetected in the bloodstream.

28 Mar 2022

Novel drug combination can boost chemoimmunotherapy response in bladder cancer patients

Adding an anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of aggressive bladder tumor growth, according to a proof-of-concept study led by Cedars-Sinai Cancer investigators.

28 Mar 2022

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

Researchers study the impact of pasteurization on specific Ig concentration against SARS-CoV-2 in milk from mRNA vaccinated lactating women.

27 Mar 2022

New trial examines the effectiveness of a two-pronged immunotherapy for glioblastomas

A new clinical trial at the University of Cincinnati is studying the effectiveness of a new two-pronged immunotherapy treatment procedure to treat the most aggressive and deadly type of brain tumors, called glioblastomas. Originating from healthy brain cells, glioblastomas can form in any area of the brain.

25 Mar 2022

Researchers show how an important inhibitor binds to the A2A receptor

The A2A receptor regulates how vigorously the innate immune system attacks diseased cells.

25 Mar 2022

New model reveals how antibodies navigate pathogen surfaces like a child at play

A new study shows how antibodies select the antigens that they bind to, as they navigate the surface of pathogens like coronaviruses.

24 Mar 2022

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.

24 Mar 2022

INRS professor developing a glycoconjugate vaccine for melioidosis

The threat from Melioidosis is real. The bacterium that causes this infectious multisymptom illness is resistant to antibiotics, making diagnosis and treatment more complex and resulting in a mortality rate of up to 50%.

24 Mar 2022

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve

The National Institute of Health awarded $436,642 to associate professor of biomedical engineering, Kartik Balachandran, to study the downstream effects of acute respiratory syndrome coronavirus 2 on the aortic valve.

24 Mar 2022

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

Researchers evaluated the effectiveness of a novel vaccine candidate UB-612 against 14 SARS-CoV-2 variants, including the latest variant of concern, Omicron.

24 Mar 2022

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

For World Tuberculosis Day 2022, News Medical spoke to Dr. Maxine Caws to raise awareness of this infectious disease.

24 Mar 2022

$Metabolic-immune interaction appears to be the cause of heart failure with preserved ejection fraction$

Metabolic-immune interaction appears to be the cause of heart failure with preserved ejection fraction

The dominant form of heart failure worldwide appears to be caused by a strong, bidirectional interaction between the body's response to metabolic stress and the immune system, according to a review article written by UT Southwestern researchers and colleagues.

23 Mar 2022

New therapy makes immunologically 'cold' tumors hot enough for immune attack

Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at Albert Einstein College of Medicine has succeeded in making pancreatic tumors visible to the immune systems of mice and vulnerable to immune attack, reducing cancer metastases by 87%.

23 Mar 2022

Origins of Type 2 diabetes differ between males and females, research shows

Over the past four decades, global cases of Type 2 diabetes mellitus have skyrocketed. According to the World Health Organization, the number of people estimated to have the disease jumped from 108 million in 1980 to 422 million in 2014, with the fastest growth observed in low- and middle-income countries.

23 Mar 2022

FDA approves new treatment for patients with metastatic melanoma based on Johns Hopkins research

The U.S. Food and Drug Administration has approved a novel therapy for patients with metastatic or inoperable melanoma, an aggressive type of skin cancer.

23 Mar 2022

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use.

23 Mar 2022

Immune System News and Research

Government provides new guidance for living with COVID

Study finds less diverse circulating antibodies in aging killifish

The different actions of CBD in SARS-CoV-2 infection

One year after severe COVID-19, T cells persist against SARS-CoV-2

Tumor cells camouflage as platelets to go undetected in the bloodstream, finds study

Novel drug combination can boost chemoimmunotherapy response in bladder cancer patients

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

New trial examines the effectiveness of a two-pronged immunotherapy for glioblastomas

Researchers show how an important inhibitor binds to the A2A receptor

New model reveals how antibodies navigate pathogen surfaces like a child at play

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

INRS professor developing a glycoconjugate vaccine for melioidosis

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

Metabolic-immune interaction appears to be the cause of heart failure with preserved ejection fraction

New therapy makes immunologically 'cold' tumors hot enough for immune attack

Origins of Type 2 diabetes differ between males and females, research shows

FDA approves new treatment for patients with metastatic melanoma based on Johns Hopkins research

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Immunology eBook

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News